Development and validation of the Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD).

Ethn Dis

Division of Preventive & Behavioral Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.

Published: February 2014

Objectives: To develop and validate a self-efficacy measure of diabetes self-management, the Lifestyle Self-Efficacy Scale for Latinos with Diabetes (LSESLD), designed for low-income, Spanish-speaking Latinos with diabetes.

Design: Quantitative and qualitative methods.

Setting: Community health centers in central and western Massachusetts.

Participants: Low-income Latinos (N = 252) enrolled in a randomized diabetes self-management intervention trial.

Measures: Construct validity, internal consistency, sensitivity to change over time.

Results: The LSESLD demonstrated good internal consistency (Cronbach's alpha = .85), reasonable construct validity (moderate, significant associations between the LSESLD and validated measures of diabetes knowledge, dietary intake, physical activity, blood glucose self-monitoring, and HbA1c values), and sensitivity to intervention-related changes over time.

Conclusion: The LSESLD is a reliable and valid research instrument assessing self-efficacy related to diabetes self-management among low-income, Spanish-speaking populations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956449PMC

Publication Analysis

Top Keywords

diabetes self-management
12
lifestyle self-efficacy
8
self-efficacy scale
8
scale latinos
8
latinos diabetes
8
diabetes lsesld
8
low-income spanish-speaking
8
construct validity
8
internal consistency
8
diabetes
6

Similar Publications

Aim:  Diabetes mellitus is a prevalent disease in the Portuguese population and is associated with significant morbidity and mortality. Its proper therapeutic management is multifactorial, with lifestyle habits having a major impact. Studies show that poorer metabolic control is associated with deficient knowledge related to diabetes, lower self-efficacy, and limited patient empowerment.

View Article and Find Full Text PDF

Older adults with cognitive impairment are at risk of medication-taking errors. This study assessed the impact of providing medication adherence feedback to cognitively impaired older adults. Forty participants with mild cognitive impairment or mild dementia had their medication adherence electronically monitored for 8 weeks.

View Article and Find Full Text PDF

Aims: This analysis evaluated whether gastrointestinal (GI) adverse events (AEs) including nausea, vomiting, diarrhoea (N/V/D) and dyspepsia were associated with weight reduction with tirzepatide across the SURMOUNT-1 to -4 trials.

Materials And Methods: SURMOUNT-1 to -4 were global Phase 3 clinical trials evaluating the safety and efficacy of tirzepatide among participants with obesity or overweight with or without type 2 diabetes (T2D). Participants were randomly assigned to receive once weekly subcutaneous tirzepatide or placebo.

View Article and Find Full Text PDF

Introduction: Type 2 diabetes mellitus (T2DM) is a major burden on public health worldwide. To reduce adverse events and complications, effective T2DM self-management is required. Self-management and glycaemic control are generally poorer in lower educated people compared with higher educated people.

View Article and Find Full Text PDF

Indigenous Australians are disproportionately affected by diabetes, with a diagnosis rate nearly four times higher than people from a non-Indigenous background. This health disparity highlights the urgent need for healthcare providers to develop cultural empathy - a critical competency for delivering culturally safe and person-centered care. Cultural empathy is essential for building trust and effective communication in diabetes education and management within Indigenous people.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!